key: cord-1034246-3pig8zvl authors: Shah, Sahil H.; Garg, Anupam K.; Patel, Shiv; Yim, Wonjun; Jokerst, Jesse; Chao, Daniel L. title: Assessment of respiratory droplet transmission during the ophthalmic slit lamp exam: a particle tracking analysis date: 2020-09-25 journal: Am J Ophthalmol DOI: 10.1016/j.ajo.2020.08.046 sha: 243f24b27e283ada91e21beeccc32a75f67b6571 doc_id: 1034246 cord_uid: 3pig8zvl PURPOSE: The global COVID-19 pandemic has resulted in a renewed focus on the importance of personal protective equipment (PPE) and other interventions to decrease spread of infectious diseases. While several ophthalmology organizations have released guidance on appropriate PPE for surgical procedures and ophthalmology clinics, there is limited experimental evidence demonstrating the efficacy of various interventions that have been suggested. In this study, we evaluate high-risk aspects of the slit-lamp exam and the effect of various PPE interventions, specifically the use of a surgical mask and a slit lamp shield. DESIGN: Experimental simulation study METHODS: Setting: Single-center STUDY POPULATION: Patient Simulation MAIN OUTCOME MEASURE(S): Presence of particles in the air near or on slit lamp and simulated slit lamp examiner or simulated patient using a fluorescent surrogate of respiratory droplets. RESULTS: Simulated coughing without a mask or slit lamp shield resulted in widespread dispersion of fluorescent droplets during the model slit lamp examination. Coughing with a mask resulted in the most significant decrease in droplets, however, particles still escaped from the top of the mask. Coughing with the slit lamp shield alone blocked most of forward particle dispersion; however significant distributions of respiratory droplets were found on the slit lamp joystick and table. Coughing with both mask and slit lamp shield resulted in the least dispersion to the simulated examiner and the simulated patient. Scanning electron microscopy demonstrated particle sizes of 3-100μm. CONCLUSIONS: Masking has the greatest effect in limiting spread of respiratory droplets, while slit lamp shields and gloves also contribute to limiting exposure to droplets from SARS-CoV-2 during slit lamp examination. The COVID-19 global pandemic has had a profound effect on clinical care around the world. As a result of the outbreak, many ophthalmology clinics temporarily halted elective clinical visits and surgical procedures. Furthermore, the pandemic has resulted in fervent discussion regarding best practices to limit the spread of infectious diseases in the clinical setting. This disease, like many other upper respiratory infections, is highly transmissible via respiratory droplets, with recent reports suggesting airborne transmission of the can also occur [1] [2] [3] . Several independent ophthalmology organizations, including the American Academy of Ophthalmology (AAO), have released guidelines regarding the resumption of clinical care as well as recommendations on appropriate personal protective equipment (PPE) that should be used when performing providing patient care. AAO guidelines recommend surgical masks for patients, masks and eye protection for providers, and slit lamp breath shields 4 . However, there has been limited evidence regarding the efficacy of these interventions. As clinical activities resume, there is a need for robust data to inform use and efficacy of PPE in the clinic. Recent work compared several commercially available slit lamp shields for degree of respiratory droplet spread protection, providing necessary evidence for best clinical practice 1 . However, several open questions remain for the development of best-practice, evidence-based guidelines for PPE during the ophthalmic exam. In this study, we develop a patient cough simulator to evaluate high-risk areas of respiratory droplet contamination during a slit lamp examination ( Figure 1 ). This study was done in a single-center using a patient simulation of an ophthalmologic clinic visit as the study population. The main outcomes measured were presence of fluorescent particles in the air near or on the slit lamp, examiner, or patient. An open-source 3D head file was modified using Blender first by cutting along two planes in order to reconfigure the dimensions. Then, a boolean difference was performed using an 8.0 cm x 8.0 cm x 19.7 cm cylinder to make a cylindrical hole parallel to the head. A hole orthogonal to the previous cylinder to provide an opening at the lips for spraying GloGerm TM . The head was printed on an Ultimaker s5 with PLA, 0.2mm layer height, and 25% infill. GloGerm TM MIST, a fluorescent surrogate of respiratory droplets used in previous simulation studies, was used as a simulator for patient coughing 5 . GloGerm TM MIST was sprayed using the included pressurized spray canister, and the resulting mist was visualized using a handheld ultraviolet flashlight (Escolite 51 LED 395 nM Ultraviolet Blacklight Detector). The pressurized canister was placed inside of a 3D printed head to simulate a patient exam. Details of 3D printing are available upon request. For some trials, a blue surgical mask (3M Standard Procedure Mask) was placed over the mouth and nose. All simulated coughs were 1 second in duration. GloGerm TM velocity was calculated by measuring the distance traveled by individual droplets per frame captured at 120fps. We measured 0.057 meters traveled over 0.0083 seconds, or 7.0 m/s (Supplemental Movie 2 available at AJO.com). To capture respiratory droplets reaching the slit lamp examiner, a 78 cm x 114 cm black board was placed at the level of the oculars and imaged between trials (Figure 1b) . Some trials included a 21.5 cm x 20 cm slit lamp plastic shield hanging from the oculars of the slit-lamp. This was placed 17.5 cm from the patient, and 14 cm from the physician. A second simulation of patient breathing used a total of 3ml of GloGerm TM sprayed in 4 second intervals over 60 seconds through a syringe with an atomizer tip, which has been widely used to simulate respiratory droplets generated via breathing in the past 6-8 . All photographs and videos were taken using a tripod-mounted Sony A7III digital camera. The blacklight was placed in a stationary position and video was recorded at 120fps at 1080p resolution. Photographs were taken in a dark room with a 5-second exposure. All post-capture editing was completed in Adobe Photoshop (photos) or Adobe Premiere Pro 2020 (videos) with all changes in contrast and brightness identical in all trials. Two still frames were exported for representative images in Figure 2 . For visualization of differences between still images, photos were auto-aligned, the difference was calculated between images, then the resulting difference was inverted and thresholded. Percent droplet coverage was determined by area of respiratory droplet on the board divided by total area of an approximate 35 cm x 35 cm square on the board centered where the physician's or patient's head would be located. Carbon tape (Nisshin EM) was used to capture GloGerm TM droplets. A scanning electron microscope (SEM; FEI Apreo) was used to examine the size and morphology of droplets at an acceleration voltage of 1kV. Slow motion video recordings were taken of GloGerm TM respiratory droplets ejected from the 3D printed head to simulate a forceful cough. For reference, our simulated exit velocity of the GloGerm TM mist was measured at 7.0 m/s, consistent with previous estimates of cough velocity between 6 and 28 m/s 9 (Supplemental Movie 2 available at AJO.com). Identical recordings with a surgical mask over the patient's mouth demonstrate the drastic reduction in forward moving droplets (Figure 2b -c, Supplemental Movie 1 available at AJO.com). Of note, respiratory particles were seen ejected upwards past the nares with the facemask present (Figure 2c , white arrow). The slit lamp was next imaged before and after a simulated cough without a mask but with a slit lamp shield. When the difference between the images were calculated, we observed a majority of the respiratory droplets contained by the shield. However, we identified significant contamination on the joystick as well as the slit lamp table (Figure 2d ). We next assessed how well the surgical mask and slit lamp shield prevented respiratory droplets from reaching the examiner. We sprayed GloGerm TM mist through the simulated patient with or without a mask, and with or without a slit lamp shield present. When we compared images of the board before and after the simulated cough, we were able to identify the pattern of droplets reaching the examiner (Figure 3a) . When no protection was in place, a dense core of droplets can be seen. A shield alone was able to block most of the central droplets, however peripheral particles can still be seen (Figure 3b ). Minimal droplets were identified when the face mask was present ( Figure 2a) . Quantification of the droplet spread reaching the examiner showed significantly less percentage coverage when using either the slit lamp shield or the surgical mask than in the unprotected condition (Figure 3c , Supplemental Table 1 ). To further replicate a typical slit lamp encounter, we simulated a short respiratory burst at a reduced velocity every 5 seconds for 60 seconds (Supplemental Figure 1a-b) . In this experimental paradigm, the respiratory droplet coverage with a slit lamp shield present was not significantly different than the cough simulation. Together, these data suggest a combination of a surgical mask and a slit lamp shield can block a vast majority of forward-moving respiratory droplets. We next assessed the reverse scenario, testing the efficacy of the surgical mask and slit lamp shield in preventing respiratory droplets from the examiner from reaching the patient. We found significantly fewer droplets reaching the patient using either PPE than in the unprotected condition (Figure 3d , Supplemental Table 1 ). In fact, no droplets were detected in 3 replicates using either the facemask or the slit lamp shield. Finally, we determined the microscopic architecture of the individual droplets ( Figure 4a ) seen in the previous experiment. Using SEM, we identified 3-10 μm droplet nuclei contained within one ~150 μm respiratory droplet (Figure 4b ). In this study, we characterized the risk to ophthalmologists from patients coughing through a simulated patient slit lamp examination, as well as the risk to patients from ophthalmologists. Using simulated respiratory droplets, we found the most effective intervention for containing spread was masking for both patient and physician. When combined with a slit lamp shield, most respiratory droplets are blocked from reaching either patient or examiner. Without any protection, we also note fewer droplets reaching the patient than the examiner. As the slit lamp shield hanging from the oculars is 3 cm closer to the examiner than the patient, these data are also consistent with previous reports that closer shield distance prevents greater spread of respiratory droplets 1 . We also identify the slit lamp joystick and examination table as a high-risk area for contamination given its location under the shield, suggesting that gloves may prevent physician contact with droplets. Our simulator is likely an underestimation of particle spread, as GloGerm TM primarily forms droplets of 100 μm, which is much larger than most respiratory (>5-10 μm) or airborne particles (<5 μm) 10 . Our cough simulator is similar to other cough simulators used in the literature. We used aerosolized GloGerm TM mist as a fluorescent surrogate of expelled respiratory droplets, which has been used in other cough simulation studies in assessing respiratory droplet spread during dental anesthesia, as well as during intubation for J o u r n a l P r e -p r o o f anesthesia 11, 12 . GloGerm TM speed was estimated at 7.0 m/s (Supplemental Movie 2 available at AJO.com), consistent with previous estimates of cough velocity between 6 and 28 m/s 9 . Respiratory particles were observed escaping through the top of the mask lateral to the nose, consistent with previous findings 13, 14 , posing a potential risk when providers are close to the patient's face such as during intravitreal injections or when using a direct ophthalmoscope. While further studies are needed to fully evaluate the risk of virus transmission during these close encounters, our data suggest that use of eye protection is prudent. Recent work suggests that surgical masks may be sufficient for reducing emission of viral particles greater than 5 μm, but less effective below that range 15 . Our SEM evaluation of respiratory droplets reaching the provider identified droplets ranging from 3-100 μm, suggesting patient facemask alone is not sufficient to prevent all risk of respiratory or airborne contamination. There are many limitations to this study. First GloGerm TM MIST may not be an exact representation of respiratory secretions during a cough. While we are able to capture larger particles, many of the droplet nuclei under 1 μm are not detected by our fluorescent methodology. In addition, we only tested one size slit lamp shield and one type of mask as a proof-of-concept. Further work characterizing the efficacy of different commercially available masks and shields is necessary for a complete understanding of the risks associated with clinic visits. Additionally, many slit lamp encounters do not involve coughing by the patient or the examiner. In these cases, the risks posed by regular breathing are likely much lower than the data presented here. However, as we aim to provide data to assist with development of PPE guidelines for use in the clinic, it is appropriate to simulate commonly encountered, higher risk scenarios which will undoubtedly occur. Nonetheless we replicated a breathing simulation over 60 seconds and though still possibly an overestimation of droplet spread, we found similar droplet containment as with the cough simulation, suggesting our findings of appropriate PPE coverage are applicable to a wide range of scenarios-a conclusion also seen in other studies of slit lamp shield efficacy 16 . As ophthalmologic clinic appointments start to resume, additional data are needed to provide best evidence-based guidelines for appropriate PPE in the clinic. Our cough simulation experiments lend support for universal masking for both patient and physician, slit lamp shields, as well as gloves to limit exposure to potential SARS-CoV-2 during the ophthalmic exam. Efficacy of Slit Lamp Breath Shields Reducing transmission of SARS-CoV-2 The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission Important coronavirus updates for ophthalmologists. American Academy of Ophthalmology The use of UV fluorescent powder for COVID-19 airway management simulation training Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment Simulation as a tool for assessing and evolving your current personal protective equipment: lessons learned during the coronavirus disease (COVID-19) pandemic Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies Human Cough as a Two-Stage Jet and Its Role in Particle Transport World Health Organization, Pandemic and Epidemic Diseases, World Health Organization. Infection Prevention and Control of Epidemic-and Pandemic-Prone Acute Respiratory Infections in Health Care: WHO Guidelines Closed" supraglottic airway guided intubation during the COVID-19 pandemic: a Glo Germ TM follow up. Anesthesia and analgesia Aerosol-Generating Procedures and Simulated Cough in Dental Anesthesia Exhaled Air Dispersion during Coughing with and without Wearing a Surgical or N95 Mask A schlieren optical study of the human cough with and without wearing masks for aerosol infection control Respiratory virus shedding in exhaled breath and efficacy of face masks White lines were placed at the frontline of respiratory droplets in 4 consecutive frames to estimate average velocity. The video was then slowed down for visualization. The droplet front moved at approximately 2.25 inches or 0.057m per frame (white line)